Developing next generation microwave ablation platform for early-stage cancer treatments
HEPTA Medical has raised $6.3M in total funding. The most recent round was Series A. The last funding was announced in September 2024.
HEPTA Medical's investors include Bpifrance, MD Start, M&L Healthcare Investments, Cléry.
HEPTA Medical is headquartered in Paris, France.
Developing next generation microwave ablation platform for early-stage cancer treatments
HEPTA Medical is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"HEPTA Medical — Funding & Investors." VCBacked, September 4, 2024, https://www.vcbacked.co/company/hepta-medical. Accessed July 19, 2026.
VCBacked. (2024). HEPTA Medical — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/hepta-medical
{{cite web |title=HEPTA Medical — Funding & Investors |url=https://www.vcbacked.co/company/hepta-medical |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated